- Home
- KIDS vs QSI Comparison
KIDS vs QSI Comparison
Compare KIDS & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- QSI
- Stock Information
- Founded
- KIDS 2007
- QSI 2013
- Country
- KIDS United States
- QSI United States
- Employees
- KIDS N/A
- QSI N/A
- Industry
- KIDS Medical/Dental Instruments
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- KIDS Health Care
- QSI Health Care
- Exchange
- KIDS Nasdaq
- QSI Nasdaq
- Market Cap
- KIDS 657.7M
- QSI 633.2M
- IPO Year
- KIDS 2017
- QSI N/A
- Fundamental
- Price
- KIDS $26.39
- QSI $2.30
- Analyst Decision
- KIDS Buy
- QSI Buy
- Analyst Count
- KIDS 7
- QSI 2
- Target Price
- KIDS $36.71
- QSI $3.25
- AVG Volume (30 Days)
- KIDS 303.5K
- QSI 59.6M
- Earning Date
- KIDS 03-05-2025
- QSI 02-27-2025
- Dividend Yield
- KIDS N/A
- QSI N/A
- EPS Growth
- KIDS N/A
- QSI N/A
- EPS
- KIDS N/A
- QSI N/A
- Revenue
- KIDS $189,673,000.00
- QSI $2,266,000.00
- Revenue This Year
- KIDS $39.26
- QSI $193.90
- Revenue Next Year
- KIDS $18.08
- QSI $173.18
- P/E Ratio
- KIDS N/A
- QSI N/A
- Revenue Growth
- KIDS 33.47
- QSI 232.26
- 52 Week Low
- KIDS $21.02
- QSI $0.61
- 52 Week High
- KIDS $35.99
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- KIDS 59.96
- QSI 49.43
- Support Level
- KIDS $26.29
- QSI $2.26
- Resistance Level
- KIDS $27.60
- QSI $2.58
- Average True Range (ATR)
- KIDS 1.38
- QSI 0.53
- MACD
- KIDS 0.34
- QSI -0.12
- Stochastic Oscillator
- KIDS 76.09
- QSI 11.48
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.